Maternal blood pressure associates with placental DNA methylation both directly and through alterations in cell-type composition.
Blood pressure
Cell-type heterogeneity
DNA methylation
Epigenome-wide association study
Mesenchymal stromal cells
Placenta
Pregnancy
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
20 10 2022
20 10 2022
Historique:
received:
16
05
2022
accepted:
14
10
2022
entrez:
21
10
2022
pubmed:
22
10
2022
medline:
25
10
2022
Statut:
epublish
Résumé
Maternal blood pressure levels reflect cardiovascular adaptation to pregnancy and proper maternal-fetal exchanges through the placenta and are very sensitive to numerous environmental stressors. Maternal hypertension during pregnancy has been associated with impaired placental functions and with an increased risk for children to suffer from cardiovascular and respiratory diseases later on. Investigating changes in placental DNA methylation levels and cell-type composition in association with maternal blood pressure could help elucidate its relationships with placental and fetal development. Taking advantage of a large cohort of 666 participants, we investigated the association between epigenome-wide DNA methylation patterns in the placenta, measured using the Infinium HumanMethylation450 BeadChip, placental cell-type composition, estimated in silico, and repeated measurements of maternal steady and pulsatile blood pressure indicators during pregnancy. At the site-specific level, no significant association was found between maternal blood pressure and DNA methylation levels after correction for multiple testing (false discovery rate < 0.05), but 5 out of 24 previously found CpG associations were replicated (p-value < 0.05). At the regional level, our analyses highlighted 64 differentially methylated regions significantly associated with at least one blood pressure component, including 35 regions associated with mean arterial pressure levels during late pregnancy. These regions were found enriched for genes implicated in lung development and diseases. Further mediation analyses show that a significant part of the association between steady blood pressure-but not pulsatile pressure-and placental methylation can be explained by alterations in placental cell-type composition. In particular, elevated blood pressure levels are associated with a decrease in the ratio between mesenchymal stromal cells and syncytiotrophoblasts, even in the absence of preeclampsia. This study provides the first evidence that the association between maternal steady blood pressure during pregnancy and placental DNA methylation is both direct and partly explained by changes in cell-type composition. These results could hint at molecular mechanisms linking maternal hypertension to lung development and early origins of childhood respiratory problems and at the importance of controlling maternal blood pressure during pregnancy.
Sections du résumé
BACKGROUND
Maternal blood pressure levels reflect cardiovascular adaptation to pregnancy and proper maternal-fetal exchanges through the placenta and are very sensitive to numerous environmental stressors. Maternal hypertension during pregnancy has been associated with impaired placental functions and with an increased risk for children to suffer from cardiovascular and respiratory diseases later on. Investigating changes in placental DNA methylation levels and cell-type composition in association with maternal blood pressure could help elucidate its relationships with placental and fetal development.
METHODS
Taking advantage of a large cohort of 666 participants, we investigated the association between epigenome-wide DNA methylation patterns in the placenta, measured using the Infinium HumanMethylation450 BeadChip, placental cell-type composition, estimated in silico, and repeated measurements of maternal steady and pulsatile blood pressure indicators during pregnancy.
RESULTS
At the site-specific level, no significant association was found between maternal blood pressure and DNA methylation levels after correction for multiple testing (false discovery rate < 0.05), but 5 out of 24 previously found CpG associations were replicated (p-value < 0.05). At the regional level, our analyses highlighted 64 differentially methylated regions significantly associated with at least one blood pressure component, including 35 regions associated with mean arterial pressure levels during late pregnancy. These regions were found enriched for genes implicated in lung development and diseases. Further mediation analyses show that a significant part of the association between steady blood pressure-but not pulsatile pressure-and placental methylation can be explained by alterations in placental cell-type composition. In particular, elevated blood pressure levels are associated with a decrease in the ratio between mesenchymal stromal cells and syncytiotrophoblasts, even in the absence of preeclampsia.
CONCLUSIONS
This study provides the first evidence that the association between maternal steady blood pressure during pregnancy and placental DNA methylation is both direct and partly explained by changes in cell-type composition. These results could hint at molecular mechanisms linking maternal hypertension to lung development and early origins of childhood respiratory problems and at the importance of controlling maternal blood pressure during pregnancy.
Identifiants
pubmed: 36266660
doi: 10.1186/s12916-022-02610-y
pii: 10.1186/s12916-022-02610-y
pmc: PMC9585724
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
397Informations de copyright
© 2022. The Author(s).
Références
Genome Biol. 2017 Jan 27;18(1):19
pubmed: 28129774
Sci Rep. 2017 Jul 24;7(1):6227
pubmed: 28740155
Hypertension. 2022 Apr;79(4):773-774
pubmed: 35263160
Clin Epigenetics. 2021 Apr 29;13(1):98
pubmed: 33926513
Epigenetics. 2013 Feb;8(2):203-9
pubmed: 23314698
Nucleic Acids Res. 2004 Feb 18;32(3):e38
pubmed: 14973332
Eur J Epidemiol. 2006;21(7):485-91
pubmed: 16858621
Bioinformatics. 2013 Jan 15;29(2):189-96
pubmed: 23175756
Cell Mol Life Sci. 2022 Feb 3;79(2):115
pubmed: 35113241
Nucleic Acids Res. 2020 Jan 8;48(D1):D890-D895
pubmed: 31584095
Hypertension. 2005 Dec;46(6):1243-9
pubmed: 16230510
Endocr Rev. 2006 Apr;27(2):141-69
pubmed: 16434511
Placenta. 2020 Apr;93:74-82
pubmed: 32250742
Hum Mutat. 2013 Jun;34(6):801-11
pubmed: 23505205
Brief Bioinform. 2019 Nov 27;20(6):2224-2235
pubmed: 30239597
Genet Epidemiol. 2015 Feb;39(2):53-64
pubmed: 25537884
Epigenomics. 2017 Aug;9(8):1143-1150
pubmed: 28749184
Circulation. 2014 Mar 18;129(11):1254-61
pubmed: 24637432
Am J Hypertens. 2005 Mar;18(3):337-41
pubmed: 15797650
Hypertension. 2001 Feb;37(2 Pt 2):365-70
pubmed: 11230301
Genome Biol. 2015 Jan 22;16:8
pubmed: 25651499
BMC Med. 2022 Jan 27;20(1):35
pubmed: 35081949
Epigenetics Chromatin. 2015 Jan 27;8:6
pubmed: 25972926
Hum Mutat. 2016 Apr;37(4):396-405
pubmed: 26777464
Curr Environ Health Rep. 2020 Sep;7(3):185-197
pubmed: 32794033
Clin Epigenetics. 2019 Feb 7;11(1):20
pubmed: 30732639
Am J Epidemiol. 2011 Oct 1;174(7):797-806
pubmed: 21859836
BMC Genomics. 2021 Jan 6;22(1):6
pubmed: 33407091
Respir Res. 2019 Dec 23;20(1):292
pubmed: 31870435
Circulation. 2009 Jan 20;119(2):243-50
pubmed: 19118251
J Am Board Fam Med. 2013 Sep-Oct;26(5):529-38
pubmed: 24004705
Epidemiology. 2011 Sep;22(5):671-9
pubmed: 21730862
BMJ. 1999 Jul 10;319(7202):90
pubmed: 10398630
Stat Med. 2018 May 20;:
pubmed: 29781174
Thromb Res. 1990 Dec 1;60(5):377-84
pubmed: 1964752
BMJ. 2014 Apr 15;348:g2301
pubmed: 24735917
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Hypertension. 2022 Apr;79(4):761-772
pubmed: 34994206
Environ Pollut. 2021 Dec 1;290:118024
pubmed: 34523531
Bioinformatics. 2012 Nov 15;28(22):2986-8
pubmed: 22954632
Nat Genet. 2014 Jun;46(6):646-51
pubmed: 24747639
Environ Int. 2018 Sep;118:334-347
pubmed: 29935799
Obstet Gynecol Int. 2012;2012:684083
pubmed: 22645615
NAR Genom Bioinform. 2020 Dec 17;2(4):lqaa105
pubmed: 33554115
Elife. 2021 Oct 08;10:
pubmed: 34622777
Epigenetics. 2016 Oct 2;11(10):730-739
pubmed: 27564456
Hypertension. 2020 Apr;75(4):1117-1124
pubmed: 32078381
BMC Bioinformatics. 2017 Feb 13;18(1):105
pubmed: 28193155
Obstet Gynecol. 2001 Apr;97(4):515-20
pubmed: 11275020
BMC Bioinformatics. 2010 Nov 30;11:587
pubmed: 21118553
Stat Methods Med Res. 2017 Feb;26(1):437-452
pubmed: 25213115
Epigenetics. 2015;10(8):717-26
pubmed: 26237075
Dev Cell. 2016 Oct 24;39(2):239-253
pubmed: 27720610
Hypertension. 1989 Apr;13(4):392-400
pubmed: 2522417
Front Genet. 2019 Sep 10;10:816
pubmed: 31552104
Hypertension. 2012 Jun;59(6):1241-8
pubmed: 22526257
Eur Respir J. 2018 Nov 29;52(5):
pubmed: 30309974
Int J Obes (Lond). 2020 Jun;44(6):1406-1416
pubmed: 32071425
BMC Pregnancy Childbirth. 2020 Jan 8;20(1):25
pubmed: 31914950
Bioinformatics. 2016 Jan 15;32(2):286-8
pubmed: 26424855
J Hypertens. 2011 Sep;29(9):1703-11
pubmed: 21841545
Epidemiology. 2012 Jan;23(1):1-9
pubmed: 22157298
Hypertension. 2019 Aug;74(2):375-383
pubmed: 31230546
Hypertension. 2008 Apr;51(4):970-5
pubmed: 18259009
Int J Mol Sci. 2019 Jun 11;20(11):
pubmed: 31212604
J Hypertens. 2011 May;29(5):937-44
pubmed: 21430559
Bioinformatics. 2021 May 5;37(5):711-713
pubmed: 32805005
Hypertens Res. 2018 Jun;41(6):406-413
pubmed: 29556095
Paediatr Perinat Epidemiol. 2007 Nov;21(6):487-94
pubmed: 17937733
J Hypertens. 2010 Nov;28(11):2210-8
pubmed: 20724938
Genome Biol. 2014 Feb 04;15(2):R31
pubmed: 24495553
Int J Epidemiol. 2016 Apr;45(2):353-63
pubmed: 26283636
PLoS Genet. 2019 Aug 1;15(8):e1008236
pubmed: 31369552
Commun Biol. 2023 Mar 13;6(1):264
pubmed: 36914823
Br Med J (Clin Res Ed). 1982 Oct 2;285(6346):919-23
pubmed: 6811068
BMC Med. 2019 Sep 11;17(1):167
pubmed: 31506067